New findings presented at the annual scientific meeting of the American Heart Association (AHA) and published in the The New England Journal of Medicine show that prescription-grade niacin may be more effective in lowering cholesterol than the popular cholesterol-lowering drugs Zetia and Vitorin. The 208-patient study—which was funded by Abbott Laboratories, the manufacturer of Niaspan, a prescription-grade niacin product—concluded that Niaspan lowered levels of plaque in patients’ arteries more effectively than its drug counterparts.

From Nutrition Business Journal.

Superfoods cover image

Play The Is It Healthy Game!

Read Nutrition News

Making Healthy Choices Easier Than You Think

You have Successfully Subscribed!